| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | +16.7% |
| Cost of Revenue | $1.4M | +3.5% |
| Gross Profit | $605K | +67.8% |
| R&D Expense | $593K | -53.0% |
| SG&A Expense | $3.3M | -29.8% |
| Operating Income | -$3.3M | +41.3% |
| Net Income | -$3.7M | +32.7% |
| EPS (Basic) | -$0.76 | +34.5% |
| EPS (Diluted) | -$0.76 | +34.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.0M | -42.5% |
| Accounts Receivable | $200K | +47.8% |
| Inventory | $116K | +146.4% |
| Current Assets | $1.5M | -27.7% |
| Total Assets | $4.1M | +15.4% |
| Current Liabilities | $2.5M | +81.8% |
| Total Liabilities | $4.2M | +99.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | +26.1% |
| Financing Cash Flow | $1.2M | +296.0% |
| -$19K |
| -101.3% |